Effect of saturated fatty acids on tacrolimus-loaded liquid crystalline nanoparticles

Journal of Drug Delivery Science and Technology

Volumn 23, Issue 2, 2013, Pages 137-141

  Thapa, R K ^a   Baskaran, R ^a   Madheswaran, T ^a   Rhyu, J Y ^a   Kim, J O ^a   Yong, C S ^a   Yoo, B K ^b  

^a Yeungnam University   (South Korea)

^b Gachon University College of Medicine   (South Korea)

Author keywords

In vitro release; Liquid crystalline nanoparticles; Monoolein; Saturated fatty acid; Tacrolimus

Indexed keywords

ARACHIDIC ACID; CARBON; GLYCEROL OLEATE; LAURIC ACID; LIQUID CRYSTALLINE NANOPARTICLE; MYRISTIC ACID; NANOPARTICLE; PALMITIC ACID; POLOXAMER; SATURATED FATTY ACID; STEARIC ACID; TACROLIMUS; UNCLASSIFIED DRUG;

ARTICLE; CHEMICAL COMPOSITION; DISPERSION; DRUG FORMULATION; DRUG RELEASE; IN VITRO STUDY; MICROSCOPY; MORPHOLOGY; PARTICLE SIZE; TRANSMISSION ELECTRON MICROSCOPY;

EID: 84876546197     PISSN: 17732247     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1773-2247(13)50021-9     Document Type: Article

References (27)

1. Spicer P. - Cubosome nanoparticles. - SciTopics, 2008, retrieved December 21, 2011, from http://www.scitopics.com/Cubosome-Nanoparticles.html.
2. Tiberg F., Johnsson M. - Drug delivery applications of nonlamellar liquid crystalline phases and nanoparticles. - J. Drug Del. Sci. Tech., 21, 101-109, 2011.
3. Kulkarni C.V., Wachter W., Iglesias-Salto G., Engelskirchen S., Ahualli S. - Monoolein: a magic lipid? - Phys. Chem. Chem. Phys., 13, 3004-3021, 2011.
4. Larsson K., Fontell K., Krog N. - Structural relationships between lamellar, cubic and hexagonal phases in monoglyceride-water systems. Possibility of cubic structure in biological systems. -Chem. Phys. Lipids, 27, 321-328, 1980.
5. Larsson K.J. - Cubic lipid-water phases: structure and biomembranes aspects. - J. Phys. Chem., 93, 7304-7314, 1989.
6. Qiu H., Caffrey M. - The phase diagram of the monoolein/water system: Metastability and equilibrium aspects. - Biomaterials, 21, 223-234, 2000.
7. Shah J.C., Sadhale Y., Chilukuri D.M. - Cubic phase gels as drug delivery systems. - Adv. Drug Deliv. Rev., 47, 229-250, 2001. (Pubitemid 32324116)
8. Johnsson M., Barauskas J., Norlin A., Tiberg F. - Physicochemical and drug delivery aspects of lipid-based liquid crystalline nanoparticles: a case study of intravenously administered propofol. - J. Nanosci. Nanotechnol., 9-10, 3017-3024, 2006. (Pubitemid 44579977)
9. Boyd B.J., Whittaker D.V., Khoo S., Davey G. - Hexosomes formed from glycerate surfactants, Formulation as a colloidal carrier for irinotecan. - Int. J. Pharm., 318, 154-162, 2006. (Pubitemid 43977801)
10. Zeevi A., Duquesnoy R., Eiras G., Rabinowich H., Todo S., Makowa L., Starzl T.E. - Immunosuppressive effect of FK506 on in vitro lymphocyte alloactivation. - Transplant Proc., 19, 40-44, 1987. (Pubitemid 17157077)
11. Starzl T.E., Todo S., Fung J., Demetris A.J., Venkataramman R., Jain A. - FK506 for liver, kidney, and pancreas transplantation. - Lancet, II, 1000-1004, 1989. (Pubitemid 19257914)
12. Todo S., Fung J., Starzl T.E., Tzakis A., Demetris A.J., Kormos R., Jain A., Alessiani M., Takaya S., Shapiro R. - Liver, kidney, and thoracic organ transplantation under FK506. - Ann. Surg., 212, 295-302, 1990.
13. Russell J.J. - Topical tacrolimus: a new therapy for atopic dermatitis. - Am. Fam. Physician, 66, 1899-1903, 2002.
14. Yamamoto T. - Topical tacrolimus for psoriasis. - Open Allergy J., 2, 51-55, 2009.
15. Tamura S., Ohike A., Ibuki R., Amidon G.L., Yamashita S. -Tacrolimus is a class II low-solubility high permeability drug: the effect of P-glycoprotein efflux on regional permeability of tacrolimus in rats. - J. Pharm. Sci., 91, 719-729, 2001. (Pubitemid 34639635)
16. Tanojo H., Bouwstra J.A., Junginger H.E., Bodde H.E. - In vitro human skin barrier modulation by fatty acids: skin permeation and thermal analysis studies. - Pharm. Res., 14, 42-49, 1997. (Pubitemid 27113313)
17. Santoyo S., Ygartua P. - Effect of skin pretreatment with fatty acids on percutaneous absorption and skin retention of piroxicam after its topical application. - Eur. J. Pharm. Biopharm., 50, 245-250, 2000.
18. Elyan B.M., Sidhom M.B., Plakogiannis F.M. - Evaluation of the different fatty acids on the percutaneous absorption of metaproterenol sulfate. - J. Pharm. Sci., 85, 101-105, 1996. (Pubitemid 26029078)
19. Kim M.J., Doh H.J., Choi M.K., Chung S.J., Shim C.K., Kim D.D., Kim J.S., Yong C.S., Choi H.G. - Skin permeation enhancement of diclofenac by fatty acids. - Drug Delivery, 15, 303-309, 2008.
20. Esposito E., Cortesi R., Drechsler M., Paccamiccio L., Mariani P., Contado C., Stellin E., Menegatti E., Bonina F., Puglia C. -Liquid crystalline nanoparticle dispersions as delivery systems for percutaneous administration of indomethacin. - Pharm. Res., 22, 2163-2173, 2005. (Pubitemid 41821596)
21. Lai J., Chen J., Lu Y., Sun J., Hu F., Yin Z., Wu W. - Glyceryl monooleate/poloxamer 407 cubic nanoparticles as oral drug delivery systems. I. In vitro evaluation and enhanced oral bioavailability of the poorly water-soluble drug simvastatin. - AAPS PharmSciTech., 10, 960-966, 2009.
22. Spicer P.T. - Cubosomes: bicontinuous cubic liquid crystalline nanostructured particles. - In: Marcel Dekker Encyclopedia of Nanoscience and Nanotechnology, J.A. Schwarz, C. Contescu, K. Putyera (Eds.), Marcel Dekker, New York, 2003, p. 881-892.
23. Spicer P.T., Hayden K.L. - Novel process for producing cubic liquid crystalline nanoparticles (liquid crystalline nanoparticles). - Langmuir, 17, 5748-5756, 2001. (Pubitemid 35330732)
24. Winter R. - Synchrotron X-ray and neutron small-angle scattering of lyotropic lipid mesophases, model biomembranes and proteins in solution at high pressure. - Biochim. Biophys. Acta, 1595, 160-184, 2002. (Pubitemid 34449700)
25. Borne J., Nylander T., Khan A. - Phase behavior and aggregate formation for the aqueous monoolein system mixed with sodium oleate and oleic acid. - Langmuir, 17, 7742-7751, 2001. (Pubitemid 35330942)
26. Trickler W.J., Nagvekar A.A., Dash A.K. - A novel nanoparticle formulation for sustained paclitaxel delivery. - AAPS PharmSciTech. 9, 486-493, 2008.
27. Lai J., Lu Y., Yin Z., Hu F., Wu W. - Pharmacokinetics and enhanced oral bioavailability in beagle dogs of cyclosporine A encapsulated in glyceryl monooleate/poloxamer 407 cubic nanoparticles. - Int. J. Nanomed., 5, 13-23, 2010.